Literature DB >> 18037116

Takayasu arteritis: what is the long-term prognosis?

Kathleen Maksimowicz-McKinnon1, Gary S Hoffman.   

Abstract

Takayasu arteritis (TA) is a form of idiopathic large vessel vasculitis that predominantly affects women of reproductive age. Although TA is a rare disease, the interpretation of longitudinal data from several countries provides new insights into the clinical course and outcomes in TA across different racial and ethnic groups. Contemporary studies belie prior perceptions of TA as a disease with a self-limited, benign course. We now recognize this disease as one that often relapses, leaves the patient chronically dependent on glucocorticoids for disease control, and frequently leads to disability. Limited data suggest that the targeted inhibition of tumor necrosis factor (TNF) might be an effective therapy for TA.

Entities:  

Mesh:

Year:  2007        PMID: 18037116     DOI: 10.1016/j.rdc.2007.07.014

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  17 in total

Review 1.  Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.

Authors:  P I Novikov; I O Smitienko; S V Moiseev
Journal:  Clin Rheumatol       Date:  2013-09-01       Impact factor: 2.980

2.  Basic clinical examination skills may save lives.

Authors:  Eoghan M McCarthy; Gaye Cunnane
Journal:  Rheumatol Int       Date:  2008-08-12       Impact factor: 2.631

3.  Anti-cytokine treatment for Takayasu arteritis: State of the art.

Authors:  Enrico Tombetti; Maria Chiara Di Chio; Silvia Sartorelli; Enrica Bozzolo; Maria Grazia Sabbadini; Angelo A Manfredi; Elena Baldissera
Journal:  Intractable Rare Dis Res       Date:  2014-02

4.  18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis.

Authors:  Elena Incerti; Enrico Tombetti; Federico Fallanca; Elena M Baldissera; Pierpaolo Alongi; Elisabetta Tombolini; Silvia Sartorelli; Maria Grazia Sabbadini; Maurizio Papa; Francesco De Cobelli; Justin C Mason; Luigi Gianolli; Angelo A Manfredi; Maria Picchio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02-08       Impact factor: 9.236

Review 5.  Clinical diagnosis and management of large vessel vasculitis: Takayasu arteritis.

Authors:  Soumya Chatterjee; Scott D Flamm; Carmela D Tan; E Rene Rodriguez
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

6.  Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.

Authors:  Nan Shao; Huixin Jia; Yiwen Li; Jingying Li
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

7.  Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques.

Authors:  Daniele Souza Freitas; Cintia Zumstein Camargo; Henrique Ataíde Mariz; Anne Elizabeth Diniz Arraes; Alexandre Wagner Silva de Souza
Journal:  Rheumatol Int       Date:  2010-12-09       Impact factor: 2.631

8.  Aortic valve replacement surgery for a case of infantile Takayasu arteritis.

Authors:  Hye Won Kwon; Yoon Jung Suh; Ji Seok Bang; Bo Sang Kwon; Gi Beom Kim; Eun Jung Bae; Woong Han Kim; Chung Il Noh
Journal:  Korean J Pediatr       Date:  2012-07-17

9.  Effect of CRP value on 18F-FDG PET vascular positivity in Takayasu arteritis: a systematic review and per-patient based meta-analysis.

Authors:  Léa Gomez; Philippe Chaumet-Riffaud; Nicolas Noel; Olivier Lambotte; Cécile Goujard; Emmanuel Durand; Florent L Besson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-30       Impact factor: 9.236

10.  Mid-aortic syndrome secondary to Takayasu's disease.

Authors:  Kai Chun Andrew Cheng; Yan-Lin Li
Journal:  BMJ Case Rep       Date:  2017-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.